Related Experiment Videos
Microencapsulated ciliary neurotrophic factor: physical properties and biological activities
D Maysinger1, K Krieglstein, J Filipovic-Grcic
1Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada.
Experimental Neurology
|April 1, 1996
Summary
Microencapsulation of ciliary neurotrophic factor (CNTF) in specific biopolymers offers a promising strategy for treating neurodegenerative disorders by enabling controlled, long-term drug release and minimizing adverse effects. This approach ensures the biological stability and sustained delivery of CNTF.
Area of Science:
- Biomedical Engineering
- Neuroscience
- Drug Delivery Systems
Background:
- Controlled drug delivery to the central and peripheral nervous systems remains a challenge for neurodegenerative disorder treatments.
- Systemic administration of ciliary neurotrophic factor (CNTF) can lead to adverse side effects, necessitating alternative delivery methods.
- CNTF is crucial for neuronal survival and differentiation but requires precise delivery to be therapeutically effective.
Purpose of the Study:
- To develop and evaluate microencapsulated formulations of CNTF for controlled release.
- To investigate the long-term release kinetics and biological stability of CNTF from various biopolymer microspheres.
- To assess the efficacy of encapsulated CNTF in supporting neuronal survival and outgrowth.
Main Methods:
- Preparation of microspheres using chitosans, alginates, and copolymers containing CNTF or engineered cells.
- Characterization of microsphere size distribution and surface morphology using image analysis and electron microscopy.
- Quantification of CNTF content and release rates via ELISA and in vitro bioassays.
Main Results:
- Chitosan and copolymerized lactic/glycolic acid microspheres achieved long-term CNTF release (up to 24 days).
- Alginate microspheres provided shorter-term release (2-12 days).
- Encapsulated CNTF demonstrated biological stability, supporting neuron survival and neurite outgrowth in vitro. Engineered cells synthesized and released functional CNTF within microspheres.
Conclusions:
- Microencapsulation is a viable strategy for controlled, sustained delivery of CNTF, mitigating systemic side effects.
- Biopolymer selection influences CNTF release kinetics, with specific combinations enabling long-term delivery.
- These findings support further investigation of encapsulated CNTF in animal models of neurodegenerative diseases.